Chembio Diagnostics Inc. (CEMI) Fundamentals

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.
SHARE INFORMATION
Market Cap$ 12,694,335
Shares Outstanding30,224,606
Float29,797,055
Percent Float98.59%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 36,926,726
Latest Fiscal EPS$ -1.42
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions114
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months954,747
Institutional Holdings Percent20.1%
Institutional Sold Previous 3 Months1,814,663
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months146,286
Insider Holdings Percent7.8
Insider Sold Previous 3 Months-
Insider Shares Owned2,347,911
TRADING INFO
52 Week High$ 2.61
52 Week Low$ 0.34
52 Week High Change$ -83.33
21 Day Moving Average$ 0.4826
21 Day Extended Moving Average$ 0.480661
50 Day Moving Average$ 0.6654
50 Day Extended Moving Average$ 0.593987
200 Day Moving Average$ 0.812873
200 Day Extended Moving Average$ 1.0389
10 Day Average Volume468,040
20 Day Average Volume1,174,822
30 Day Average Volume1,075,390
50 Day Average Volume1,838,314
Alpha-0.018357
Beta1.6523
Standard Deviation0.287354
R20.084180
7 Day Price Change$ 0.066
7 Day Percent Change18.64%
21 Day Price Change$ -0.1249
21 Day Percent Change-22.92%
30 Day Price Change$ -0.2206
30 Day Percent Change-34.44%
Month to Date Price Change$ -0.1857
Month to Date Percent Change-30.66%
Quarter to Date Price Change$ -0.23
Quarter to Date Percent Change-35.38%
180 Day Price Change$ -0.4405
180 Day Percent Change-51.19%
200 Day Price Change$ -0.2789
200 Day Percent Change-39.91%
Year to Date Price Change$ -0.72
Year to Date Percent Change-63.16%

Chembio Diagnostics Inc. (CEMI) Key Ratios

PROFITABILITY
EBIT Margin-59.9%
EBITDA Margin-54.9%
Pre-Tax Profit Margin-51.3%
Profit Margin Count-65.39%
Gross Margin9.3%
Profit Margin TOT-65.39%
INCOME STATEMENTS
Revenue$ 55,348,298
Revenue Per Share$ 1.5638
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity1.30
Int Coverage-11.30
Current Ratio2.90
Leverage Ratio2.20
Quick Ratio1.90
Long Term Debt To Capital0.53
VALUATION MEASURES
PE Ratio-0.30
Enterprise Value$ 15,046,199
Price to Sales0.268569
Price to Free Cash-0.50
PE High Last 5 Years-6.50
Price To Book0.60
Price To Cash Flow649.30
PE Low Last 5 Years-9.30
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover14.60
Invoice Turnover4.00
Assets Turnover0.90
Return Assets-72.25
Return on Equity-216.99
Return on Capital-78.81

Chembio Diagnostics Inc. (CEMI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEORichard L. Eberly
Emplyoees337
Last AuditUE
CIK0001092662
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address555 Wireless Boulevard
Hauppauge, NY 11788
Websitehttp://www.chembio.com
Facsimile+1 631 924-2065
Telephone+1 631 924-1135
Emailinvestor@chembio.com
Your Recent History
NASDAQ
CEMI
Chembio Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221002 19:32:45